Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2025 Filed Mar 3, 2025 14:25 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 1,300 | $4.21 | $5,473.00 |
DisclosureSEC source: 0001474506-25-000049 · primary_doc.xml · nonDerivative · entry 4 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,777 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (20) to this Form 4. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.40, inclusive. Read SEC document |
| January 28, 2025 Filed Mar 3, 2025 14:25 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 400 | $3.84 | $1,536.00 |
DisclosureSEC source: 0001474506-25-000049 · primary_doc.xml · nonDerivative · entry 3 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,477 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (20) to this Form 4. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.82 to $3.86, inclusive. Read SEC document |
| January 27, 2025 Filed Mar 3, 2025 14:25 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 300 | $3.89 | $1,167.00 |
DisclosureSEC source: 0001474506-25-000049 · primary_doc.xml · nonDerivative · entry 2 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,077 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (20) to this Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.90, inclusive. Read SEC document |
| January 23, 2025 Filed Mar 3, 2025 14:25 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $4.09 | $409.00 |
DisclosureSEC source: 0001474506-25-000049 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,777 Read SEC document |
| January 22, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $4.06 | $406.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 30 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,677 Read SEC document |
| January 16, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 300 | $4.52 | $1,356.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 29 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,577 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.49 to $4.54, inclusive. Read SEC document |
| January 15, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $4.44 | $444.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 28 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,277 Read SEC document |
| January 14, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $4.51 | $902.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 27 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,177 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.36 to $4.66, inclusive. Read SEC document |
| January 13, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $4.68 | $468.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 26 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,977 Read SEC document |
| January 10, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 400 | $4.47 | $1,788.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 25 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,877 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.72, inclusive. Read SEC document |
| January 08, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $4.76 | $476.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 24 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,477 Read SEC document |
| January 07, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 300 | $4.32 | $1,296.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 23 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,377 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.36, inclusive. Read SEC document |
| January 06, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $4.44 | $888.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 22 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,077 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.46, inclusive. Read SEC document |
| January 03, 2025 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 400 | $4.25 | $1,700.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 21 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,877 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.37, inclusive. Read SEC document |
| December 30, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 350 | $4.50 | $1,575.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 20 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,477 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.39 to $4.66, inclusive. Read SEC document |
| December 26, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 260 | $4.68 | $1,216.80 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 19 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,127 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.97, inclusive. Read SEC document |
| December 24, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 250 | $4.45 | $1,112.50 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 18 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,867 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.43 to $4.49, inclusive. Read SEC document |
| December 20, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $5.01 | $1,002.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 17 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,617 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. Read SEC document |
| December 19, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 50 | $5.46 | $273.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 16 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,417 Read SEC document |
| December 18, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 50 | $5.44 | $272.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 15 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,367 Read SEC document |
| December 17, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $5.54 | $1,108.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 14 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,317 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.52 to $5.55, inclusive. Read SEC document |
| December 16, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $5.47 | $547.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 13 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,117 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.55, inclusive. Read SEC document |
| December 13, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 150 | $5.56 | $834.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 12 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,017 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.54 to $5.59, inclusive. Read SEC document |
| December 12, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $5.68 | $1,136.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 11 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,867 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.64 to $5.71, inclusive. Read SEC document |
| December 11, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $5.80 | $1,160.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 10 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,667 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.67 to $5.93, inclusive. Read SEC document |
| December 10, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 200 | $5.89 | $1,178.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 9 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,467 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $5.89, inclusive. Read SEC document |
| December 09, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 100 | $5.76 | $576.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 8 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,267 Read SEC document |
| December 06, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 300 | $5.52 | $1,656.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 7 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,167 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 to $5.59, inclusive. Read SEC document |
| December 05, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 50 | $5.61 | $280.50 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 6 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,867 Read SEC document |
| December 03, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 25 | $5.65 | $141.25 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 5 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,817 Read SEC document |
| November 29, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 225 | $5.78 | $1,300.50 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 4 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,792 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (19) to this Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.76 to $5.84, inclusive. Read SEC document |
| November 27, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 25 | $6.18 | $154.50 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 3 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,567 Read SEC document |
| November 26, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 25 | $6.10 | $152.50 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 2 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,542 Read SEC document |
| November 25, 2024 Filed Mar 3, 2025 13:50 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 10 | $6.00 | $60.00 |
DisclosureSEC source: 0001474506-25-000048 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,517 Read SEC document |
| October 24, 2024 Filed Oct 24, 2024 23:01 UTC |
Ross JackDirector · CEO and Chairman · 10% owner
|
PurchaseCommon Stock, par value $0.00001 per share | 300,000 | $9.00 | $2,700,000.00 |
DisclosureSEC source: 0001474506-24-000226 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Rosscor Brands Corp. Disclosed balance after: 300,000 F1 · balance_after: The shares of Common Stock are owned directly by Rosscor Brands Corp., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 19, 2020 Filed Jun 2, 2020 20:42 UTC |
Ross JackDirector · President, CEO and CFO · 10% owner
|
PurchaseCommon Stock | 3,000,000 | $0.15 | $450,000.00 |
DisclosureSEC source: 0001474506-20-000177 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · President, CEO and CFO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Gowan Capital Inc. Disclosed balance after: 4,625,034 F1 · ownership.nature: The shares of Common Stock are owned directly by Gowan Capital Inc., which is controlled by the Reporting Person. The Reporting Person is the indirect beneficial owner of the reported securities. Read SEC document |
| January 21, 2020 Filed Jan 21, 2020 17:13 UTC |
Ross JackDirector · President and CEO · 10% owner
|
PurchaseCommon Stock, $0.00001 par value per share | 228,572 | $0.04 | $9,988.60 |
DisclosureSEC source: 0001474506-20-000018 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Gowan Capital Inc. Disclosed balance after: 1,853,606 F1 · ownership.nature: The shares of Common Stock are owned directly by Gowan Capital Inc., which is controlled by the Reporting Person. The Reporting Person is the indirect beneficial owner of the reported securities. Read SEC document |
| December 10, 2018 Filed Dec 11, 2018 21:08 UTC |
Ross JackDirector · President and CEO · 10% owner
|
PurchaseCommon Stock, $0.00001 par value per share | 1,225,034 | $0.55 | $673,768.70 |
DisclosureSEC source: 0001474506-18-000083 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Gowan Capital Inc. Disclosed balance after: 1,225,034 F1 · ownership.nature: The shares of Common Stock are owned directly by Gowan Capital Inc., which is controlled by the Reporting Person. The Reporting Person is the indirect beneficial owner of the reported securities. Read SEC document |
| December 10, 2018 Filed Dec 21, 2018 16:40 UTC Amendment |
Ross JackDirector · President and CEO · 10% owner
|
PurchaseCommon Stock, $0.00001 par value per share | 1,225,034 | $0.55 | $673,768.70 |
DisclosureSEC source: 0001474506-18-000095 · primary_doc.xml · nonDerivative · entry 1 Ross Jack · CIK 0001626921 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Gowan Capital Inc. Disclosed balance after: 1,625,034 F1 · balance_after: This item has been corrected to reflect the correct number of securities beneficially owned following the reported transaction. F2 · ownership.nature: The shares of Common Stock are owned directly by Gowan Capital Inc., which is controlled by the Reporting Person. The Reporting Person is the indirect beneficial owner of the reported securities. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 12:51 UTC Amendment |
KNIGHT THERAPEUTICS INTERNATIONAL SA10% owner
|
OtherStock Options · Derivative | 1 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001019056-16-001718 · synergy_4a.xml · derivative · entry 4 Knight Therapeutics (Barbados) Inc. · CIK 0001632373 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,000,000 shares Expires 2025-12-14 F1 · kind: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. F1 · price: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 12:51 UTC Amendment |
KNIGHT THERAPEUTICS INTERNATIONAL SA10% owner
|
OtherWarrants · Derivative | 1 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001019056-16-001718 · synergy_4a.xml · derivative · entry 3 Knight Therapeutics (Barbados) Inc. · CIK 0001632373 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 4,547,243 shares Expires 2025-11-12 F1 · kind: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. F1 · price: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 12:51 UTC Amendment |
KNIGHT THERAPEUTICS INTERNATIONAL SA10% owner
|
OtherWarrants · Derivative | 1 | Not disclosed Strike: $0.34 | Not disclosed |
DisclosureSEC source: 0001019056-16-001718 · synergy_4a.xml · derivative · entry 2 Knight Therapeutics (Barbados) Inc. · CIK 0001632373 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,584,759 shares Expires 2025-01-22 F1 · kind: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. F1 · price: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 12:51 UTC Amendment |
KNIGHT THERAPEUTICS INTERNATIONAL SA10% owner
|
OtherCommon Stock | 7,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-16-001718 · synergy_4a.xml · nonDerivative · entry 1 Knight Therapeutics (Barbados) Inc. · CIK 0001632373 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,645,812 F1 · kind: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. F1 · price: The Reporting Person received 7,500,000 common shares in the capital of the Issuer as consideration for the cancellation of the following derivative securities: (i) a share purchase warrant dated January 22, 2015 exercisable into 3,584,759 common shares of the Issuer, (ii) a share purchase warrant dated November 12, 2015 exercisable into 4,547,243 common shares of the Issuer, and (iii) stock options with respect to 1,000,000 common shares of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.